Document Detail


Determinants of left ventricular hypertrophy and its progression in high-flux haemodialysis.
MedLine Citation:
PMID:  12601259     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To identify factors contributing to the development and progression of left ventricular hypertrophy (LVH) in patients on high-flux haemodialysis. METHOD: Fifty patients without clinical cardiac disease underwent baseline echocardiography, related measurements and follow-up studies 6-12 months later. RESULTS: Residual urea clearance was lower (0.7 +/- 1.1 vs. 2.2 +/- 2.4 ml/min; p = 0.034) while systolic blood pressure (162 +/- 21 vs. 147 +/- 11 mm Hg; p = 0.003), duration of dialysis dependence (38 +/- 37 vs. 17 +/- 13 months; p = 0.004) and interdialytic weight gain (1.98 + 0.84 vs. 1.32 + 1.08 kg; p = 0.026) were higher in those with LVH. Parathyroid hormone changed less in those whose LVH regressed (186 +/- 89 vs. 303 +/- 280 pg/ml; p = 0.032). Regression did not occur when parathyroid hormone was >300 pg/ml. ACE gene polymorphism did not affect LVH development or progression. CONCLUSION: Systolic hypertension, duration of dialysis dependence and high interdialytic weight gains promote LVH. Hyperparathyroidism retards LVH regression.
Authors:
Chiew H Kong; Ken Farrington
Related Documents :
10619589 - Reduction in arterial distensibility in hypertensive patients as evaluated by ambulator...
21220729 - Determinants of blood pressure in preschool children: the role of parental smoking.
1822029 - Cellular basis of aging in the mammalian heart.
3742749 - Septal geometry in the unloaded living human heart.
3880999 - Pattern of left ventricular diastolic filling in chronic aortic regurgitation: a gated ...
742729 - Hemodynamic effects of phentolamine in valvular abnormalities.
12771599 - Endogenous glycosides in critically ill patients.
16374419 - 'hypertension' and 'microalbuminuria': the bell tolls for thee.
3740309 - Changes in forebrain hexokinase activity after aortic baroreceptor denervation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Blood purification     Volume:  21     ISSN:  0253-5068     ISO Abbreviation:  Blood Purif.     Publication Date:  2003  
Date Detail:
Created Date:  2003-02-25     Completed Date:  2003-10-03     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8402040     Medline TA:  Blood Purif     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  163-9     Citation Subset:  IM    
Copyright Information:
Copyright 2003 S. Karger AG, Basel
Affiliation:
Renal Unit, Lister Hospital, Stevenage, UK. chiew@kch86.fsnet.co.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Disease Progression
Female
Follow-Up Studies
Humans
Hyperparathyroidism / blood,  complications
Hypertension / epidemiology
Hypertrophy, Left Ventricular / etiology*,  physiopathology,  ultrasonography
Kidney Failure, Chronic / complications,  therapy*
Male
Middle Aged
Parathyroid Hormone / blood
Peptidyl-Dipeptidase A / genetics
Polymorphism, Genetic
Renal Dialysis / adverse effects*,  methods
Risk Factors
Weight Gain
Chemical
Reg. No./Substance:
0/Parathyroid Hormone; EC 3.4.15.1/Peptidyl-Dipeptidase A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Patients on chronic hemodialysis have no intrinsic lymphocyte defect upon stimulation with interleuk...
Next Document:  End-stage renal failure patients requiring renal replacement therapy in the intensive care unit: inc...